Clinical Evaluation Report (CER) Analysis
Clinical Evaluation Report (CER) analysis helps Clinical Affairs and Regulatory Affairs Teams evaluate clinical evidence quality, benefit-risk support, and MDR readiness before formal notified body regulatory review decisions.
What Clinical Teams Can Decide From the Analysis
Is CER scope clearly defined?
Identify if the CER defines device scope and intended use so teams can confirm review boundaries before approval.
Where could MDR evidence gaps appear?
Spot missing literature methodology or broken PMS traceability before they create submission risk or governance delay during review.
Can teams make a more defensible submission decision?
Evaluate whether the CER provides enough clinical evidence for Regulatory Affairs to submit for external review with confidence.
How Teams Use This Analysis
Clinical Affairs and Regulatory Affairs Teams use Clinical Evaluation Report (CER) analysis to review clinical evidence packages more consistently, catch regulatory evidence gaps earlier, and turn literature findings into decisions about CER defensibility and MDR readiness.
Traceability Verification
Turns scattered literature links into structured findings, allowing QA teams to prioritize traceability fixes, evidence follow-up, and approval decisions.
Regulatory Gap Analysis
Checks whether MDR references and linked SOPs remain aligned, reducing the chance that teams rely on outdated references or inconsistent requirements.
Evidence Reusability Check
Organizes open equivalence questions and reviewer notes into a practical follow-up path, so unresolved issues can be addressed before submission delay.
Post-Market Surveillance Readiness Assessment
Connects PMS and PMCF linkage to CER update planning, giving teams a clearer basis for clinical governance decisions.
Clinical Claims Review
Surfaces unsupported claims, weak benefit-risk rationale, and outdated PMS references, giving clinical reviewers earlier visibility into regulatory exposure before the CER reaches approval.
Clinical Evaluation Report Pre-Review
Maps structural completeness and QA readiness signals into a clearer readiness view, helping Clinical Affairs understand approval needs before regulatory review.
Key Clinical Evaluation Report (CER) Insights to Look For
Automatan organizes Clinical Evaluation Report (CER) evaluation into structured insights that help teams judge clinical evidence coverage, MDR alignment, QA readiness, and the quality of the evidence behind submission decisions.
Document Name
Report title is captured to maintain version traceability and avoid review confusion across all clinical evaluation cycles.
Document Type
The CER type provides a consistent anchor for insights, ensuring the analysis stays linked to the correct review package.
QMS Scope
A structured summary of devices covered, intended use, and lifecycle scope gives teams immediate context without scope misinterpretation.
Standards Alignment
Extracted MDR, MEDDEV, MDCG, ISO, and SOP references distinguish explicit commitments from implied intent, helping teams focus compliance planning where it matters most.
Document Control Verification
Classification of approval status versus revision status clarifies which governance lens applies and directs early document-control evidence collection.
Structural Completeness
Flags missing MDR or MEDDEV sections to highlight elevated notified body scrutiny and prioritize review efforts.
Compliance Flags
Determines supported or unsupported claim status to guide gap triage and corrective action expectations.
Traceability Integrity
CER versus supporting-record designation informs the correct traceability framework and cross-reference rules.
Device & Equivalence Scope
Device, equivalent, or comparator scope signals shape equivalence assessment and scrutiny priorities.
Clinical Data Sources
Interaction with literature, investigations, PMS, and PMCF evidence is identified, ensuring clinical data sources are properly scoped.
Literature Search Methodology
Search terms, databases, or inclusion criteria signals provide clarity on methodology scope and regulatory relevance.
Benefit-Risk Evidence
Automated extraction of benefit-risk context, such as residual risk or clinical benefit, informs conclusion defensibility and evidence requirements.
State of the Art Coverage
Directional state-of-the-art coverage signals offer early insight for CER update planning.
PMS & PMCF Linkage
PMS findings and PMCF roles anchor update reasoning and support lifecycle mapping.
Evaluator Qualifications
Identifies qualified, independent, or appropriately experienced evaluators to guide competency, independence, and documentation considerations.
QA Readiness Signal
Required blocker and major finding signals inform readiness planning and final review design.
QA Readiness Findings
Review context, including blockers, major findings, unresolved gaps, or missing approvals, ensures readiness alignment with actual approval conditions.
Reviewer Notes
Automatan compiles ambiguity, limitation, assumption, and follow-up notes to highlight potential expert-review focus areas.
Who Uses This Analysis
Clinical Evaluation Report (CER) review pulls in several stakeholders at once. Each group needs a different cut of the same document, focused on the clinical, regulatory, quality, and risk questions closest to its mandate.
Clinical Affairs Teams
Reads the CER for clinical evidence gaps, using the analysis to decide whether substantiation needs revision.
Regulatory Affairs Professionals
Reviews MDR Annex XIV coverage, helping the team identify submission gaps before notified body review.
Quality Assurance Teams
Checks document control evidence and supporting references, making sure the CER can support approval and audit review.
Medical Safety & Risk Teams
Uses the analysis to compare benefit-risk evidence against risk-management records, giving stakeholders a clearer basis for safety decisions.
Post-Market Surveillance & PMCF Teams
Targets weak PMS linkage and PMCF follow-up needs, turning the CER review into a prioritized update plan.
How Clinical Evaluation Report (CER) Analysis Connects to Your Regulatory Review Workflow
Automatan works inside the tools Clinical and Regulatory Teams already use. Clinical Evaluation Reports and supporting files can be imported from common document sources and turned into structured review intelligence without rebuilding the regulatory process.
Google Drive
Import documents directly from Google Drive so Automatan can extract clinical evidence signals and QA readiness indicators from files already stored by the team.
Add AI Integration
Google Docs
Analyze Clinical Evaluation Reports stored in Google Docs without moving files, enabling seamless extraction of MDR traceability insights within the existing workspace.
Add AI Integration
OneDrive
Access documents from OneDrive so teams in regulated medical device environments can capture benefit-risk signals directly from their repository.
Add AI Integration
Dropbox
Pull clinical evaluation reports from Dropbox to turn embedded equivalence claims, literature methods, and PMS linkages into structured regulatory intelligence inside Automatan.
Add AI IntegrationAnalyze Clinical Evaluation Reports (CERs) With Clearer Clinical Evidence
Clinical Affairs and Regulatory Affairs Teams need more than narrative. Automatan helps teams analyze Clinical Evaluation Reports (CERs) for clinical evidence quality, MDR readiness, and follow-up actions, so every review leads to clearer regulatory decisions.